Tarsus Pharmaceuticals Inc logo

Tarsus Pharmaceuticals Inc

NAS:TARS (USA)   Ordinary Shares
$ 30.98 -2.16 (-6.52%) 08:09 PM EST
At Loss
P/B:
4.54
Enterprise V:
$ 983.70M
Volume:
1.11M
Avg Vol (2M):
522.44K
Trade In:
Volume:
1.11M
At Loss
Avg Vol (2M):
522.44K

Business Description

Tarsus Pharmaceuticals Inc logo
Tarsus Pharmaceuticals Inc
NAICS : 541714 SIC : 2833
ISIN : US87650L1035

Share Class Description:

TARS: Ordinary Shares
Description
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
Name Current Vs Industry Vs History
Cash-To-Debt 9.78
Equity-to-Asset 0.79
Debt-to-Equity 0.11
Debt-to-EBITDA -0.21
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 8.8
Distress
Grey
Safe
Beneish M-Score 4.22
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 51.83
9-Day RSI 43.29
14-Day RSI 43.97
6-1 Month Momentum % 106.96
12-1 Month Momentum % 102.48

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.01
Quick Ratio 7.92
Cash Ratio 7.02
Days Inventory 268.21
Days Sales Outstanding 116.56
Days Payable 1425.62

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -19
Shareholder Yield % -9.23

Financials (Next Earnings Date:2024-08-09 Est.)

TARS's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:TARS

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Tarsus Pharmaceuticals Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 42.561
EPS (TTM) ($) -4.77
Beta 0.96
Volatility % 69.9
14-Day RSI 43.97
14-Day ATR ($) 1.962527
20-Day SMA ($) 34.586
12-1 Month Momentum % 102.48
52-Week Range ($) 12.57 - 42.5
Shares Outstanding (Mil) 37.78

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Tarsus Pharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

Tarsus Pharmaceuticals Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Tarsus Pharmaceuticals Inc Frequently Asked Questions

What is Tarsus Pharmaceuticals Inc(TARS)'s stock price today?
The current price of TARS is $30.98. The 52 week high of TARS is $42.50 and 52 week low is $12.57.
When is next earnings date of Tarsus Pharmaceuticals Inc(TARS)?
The next earnings date of Tarsus Pharmaceuticals Inc(TARS) is 2024-08-09 Est..
Does Tarsus Pharmaceuticals Inc(TARS) pay dividends? If so, how much?
Tarsus Pharmaceuticals Inc(TARS) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1